Status:
ACTIVE_NOT_RECRUITING
Evaluation of a Rapid Point-of-Care Serological Triage Test for Active TB
Lead Sponsor:
Norwegian Institute of Public Health
Collaborating Sponsors:
European and Developing Countries Clinical Trials Partnership (EDCTP)
University of Stellenbosch
Conditions:
Tuberculosis, Pulmonary
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The performance of a new triage test for active tuberculosis (TB), SeroSelectTB, will be qualified in multi-centre randomised controlled trials at health-posts in South Africa, Tanzania and Ethiopia. ...
Detailed Description
Purpose: Worldwide over 15 million persons live with active TB. While the prevalence of latent TB is very high, only disease, and not latent infection, is treated in most high burdened countries. A r...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Informed Consent Form signed
- Unwell, suspected to have TB or pneumonia
Exclusion
- Currently receiving TB treatment
- On TB treatment past 30 days or more, or last dose less than 1 month before enrolment
Key Trial Info
Start Date :
September 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
9097 Patients enrolled
Trial Details
Trial ID
NCT04752592
Start Date
September 21 2021
End Date
December 31 2025
Last Update
October 1 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Amhara region
Bahir Dar, Ethiopia
2
Stellenbosch University Clinics
Cape Town, Western Cape, South Africa, 7505
3
Kilimanjaro region, Tanzania
Moshi, Tanzania